Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2007-06-12
2007-06-12
Kwon, Brian (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S232800, C514S475000
Reexamination Certificate
active
10874384
ABSTRACT:
Methods of treating a host suffering from restenosis are provided. The methods include delivery of a stent coated with a hypoestoxide, hypoestoxide derivative or hypoestoxide agonist compound to a vessel. The methods further include the administration of a chemotherapeutic agent in combination with delivery of a stent coated with a hypoestoxide, hypoestoxide derivative or hypoestoxide agonist compound to a vessel. The chemotherapeutic agent may be coated on the stent or administered systemically.
REFERENCES:
patent: 5747474 (1998-05-01), Ojo-Amaize et al.
patent: 5801193 (1998-09-01), Ojo-Amaize et al.
patent: 5994328 (1999-11-01), Ojo-Amaize et al.
patent: 6001871 (1999-12-01), Ojo-Amaize et al.
patent: 6242484 (2001-06-01), Ojo-Amaize et al.
patent: 6441025 (2002-08-01), Li et al.
patent: 6592895 (2003-07-01), Lang et al.
patent: 6939376 (2005-09-01), Shulze et al.
patent: 2003/0065345 (2003-04-01), Weadock
patent: 2003/0109434 (2003-06-01), Algate et al.
patent: 2003/0229393 (2003-12-01), Kutryk
patent: 2005/0112071 (2005-05-01), Ojo-Amaize et al.
patent: 1 421 909 (2004-05-01), None
patent: 03/011212 (2003-02-01), None
patent: WO 03/022266 (2003-03-01), None
patent: WO 03/065881 (2003-08-01), None
“Hypoestoxide, a Natural Nonmutagenic Diterpenoid with Antiangiogenic and Antitumor Activity: Possible Mechanism of Action”, Ojo-Amaize et al., Cancer Research 62, pp. 4007-7014, Jul. 15, 2002.
(“The Cardiac Disease Epidemic”, Doug Orr, www.medicalimagingmag.com, 2003.
Drug-Eluting Intra-Coronary Stents: Have We Got the Magic Bullet?, Journal of Postgraduate Medicine, Jul. 1, 2003, Dhindsa, S.
“2000 Heart and Stroke Statistical Update,” American Heart Association, 1999, pp. 1-29.
Hong, Mun K. et al., “Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model,” Lippincott Williams & Wilkins, 2001, pp. 513-515.
Clowes, Alerander et al., “Suppression by Heparin of Smooth Muscle Cell Proliferation in Injured Arteries,” Nature, vol. 265, 1977, pp. 625-626.
“Supplement to Circulation, Abstracts from the 62ndScientific Sessions,” American Heart Association, Supplement II, Circulation, vol. 80, No. 4, 1989.
Sollott, Steven J. et al., “Taxol Inhibits Neointimal Smooth Muscle Cell Accumulation After Angioplasty in the Rat,” The Journal of Clinical Investigation, Inc., vol. 95, 1995, pp. 1869-1876.
Jonasson, Lena et al., “Cyclosporin A Inhibits Smooth Muscle Proliferation in the Vascular Response to injury,” Proc. Natl. Acad. Sci. USA, vol. 85, 1988, pp. 2303-2306.
Marx, Steven O. et al., “Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells,” American Heart Association, Inc., 1995, pp. 412-417.
Ojo-Amaize, Emmanuel et al., “Hypoextoxide, a Novel Anti-Inflammatory Natural Diterpene, Inhibits the Activity of IkB Kinase,” Cellular Immunology 209, Academic Press, 2001, pp. 149-157.
Ojo-Amaize, Emmanuel et al., “Hypoestoxide, a Natural Nonmutagenic Diterpenoid with Antiangiogenic and Antitumor: Possible Mechanims of Action,” Cancer Research, vol. 65, 2002, pp. 4007-4014.
Cottam Howard B.
Nchekwube Emeka J.
Ojo-Amaize Emmanuel A.
Immune Modulation, Inc.
Kwon Brian
Pillsbury Winthrop Shaw & Pittman LLP
LandOfFree
Hypoestoxides, derivatives and agonists thereof for use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoestoxides, derivatives and agonists thereof for use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoestoxides, derivatives and agonists thereof for use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3869064